Discovery of a Potent, Selective, and Blood-Brain Barrier Permeable Non-nitrocatechol Inhibitor of Catechol- O -methyltransferase
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Sofia Benfeito und 8 weiteren Autor:innen. Beteiligte Einrichtung: CIQUP-IMS/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal. Hauptthemen laut MEDLINE: Catechol O-Methyltransferase Inhibitors, Blood-Brain Barrier, Catechol O-Methyltransferase, Catechols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Foundation for Science and Technology, Horizon 2020 Framework Programme, Funda??o para a Ci?ncia e a Tecnologia.
Abstract (Originalsprache)
A new library of non-nitrocatechol compounds (HetCAMs) was developed and their efficacy was compared to tolcapone, a standard COMT inhibitor for PD. Compound 9 emerged as the most potent inhibitor, showing selective inhibition of brain (IC50 = 24 nM) and liver (IC50 = 81 nM) MB-COMT over liver S-COMT (IC50 = 620 nM) isoforms. Although compound 9 presented higher IC50 values than tolcapone, it was more selective for brain MB-COMT than liver S-COMT. Unlike tolcapone, compound 9 is not a tight-binding inhibitor and is less cytotoxic to HepG2 and SK-N-SH cells. Additionally, compound 9 is predicted to cross the blood-brain barrier (BBB) by passive diffusion and chelate divalent metals like Fe(II) and Cu(II). The results demonstrate the potential of this rational drug design strategy for developing new CNS-active drug candidates, offering symptom relief via COMT inhibition that can provide a long-term, disease-modifying outcome (chelation of divalent metals) in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CIQUP-IMS/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto 4169-007, Portugal.
- Department of Biomedicine - Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto 4200-319, Portugal.
- MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Porto 4200-319, Portugal.
ORCID-Profile: Sofia Benfeito, Fernando Cagide, Fernanda Borges
Förderung
- Foundation for Science and Technology
- Horizon 2020 Framework Programme
- Funda??o para a Ci?ncia e a Tecnologia
Zitieren
APA
Benfeito, S., Albuquerque, B., Sequeira, L., Lima, C., Chavarria, D., Serrão, P., Cagide, F., Soares-da-Silva, P., & Borges, F. (2024). Discovery of a Potent, Selective, and Blood-Brain Barrier Permeable Non-nitrocatechol Inhibitor of Catechol- O -methyltransferase. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01682
Vancouver
Benfeito S, Albuquerque B, Sequeira L, Lima C, Chavarria D, Serrão P, et al. Discovery of a Potent, Selective, and Blood-Brain Barrier Permeable Non-nitrocatechol Inhibitor of Catechol- O -methyltransferase. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01682
BibTeX
@article{Benfeito2024,
author = {Benfeito, Sofia and Albuquerque, Bárbara and Sequeira, Lisa and Lima, Carla and Chavarria, Daniel and Serrão, Paula and Cagide, Fernando and Soares-da-Silva, Patrício and Borges, Fernanda},
title = {Discovery of a Potent, Selective, and Blood-Brain Barrier Permeable Non-nitrocatechol Inhibitor of Catechol- O -methyltransferase},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01682}
}
EUVIMED